Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-14
2011-06-14
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S051000, C544S052000, C514S228200
Reexamination Certificate
active
07960376
ABSTRACT:
The present invention provides benzo-fused heterocyclic compounds having the structure of formula I, as well as prodrugs, stereoisomers, racemates, salts, hydrates, solvates, acid salt hydrates and isomorphic crystalline forms thereof.The compounds directly or indirectly modulate the activity of one or more cannabinoid receptors and can be incorporated into pharmaceutical preparations that are useful for the prevention and treatment of a variety of diseases and conditions, including pain, inflammation and pruritis.
REFERENCES:
patent: 4080323 (1978-03-01), Walser et al.
patent: 4118386 (1978-10-01), Walser
patent: 4687777 (1987-08-01), Meguro et al.
patent: 2003/0139394 (2003-07-01), Lubisch et al.
patent: 2007/0010670 (2007-01-01), Hirata et al.
patent: 2007/0191603 (2007-08-01), Ackermann et al.
patent: WO9925717 (1999-05-01), None
patent: WO 9925717 (1999-05-01), None
patent: WO0066124 (2000-11-01), None
patent: 2004014389 (2004-02-01), None
patent: WO2004/014389 (2004-02-01), None
patent: WO2005092872 (2005-10-01), None
patent: 2006015259 (2006-02-01), None
patent: WO2006/015259 (2006-02-01), None
patent: 2007024949 (2007-03-01), None
patent: WO2007/024949 (2007-03-01), None
patent: WO2007/050425 (2007-03-01), None
patent: 2007050425 (2007-05-01), None
patent: WO2007093507 (2007-08-01), None
patent: WO2008118141 (2008-10-01), None
patent: WO2009035997 (2009-03-01), None
Vippagunta et al, “Crystalline Solids” Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Abou-Gharbia, M. et al.,Synthesis and Structure-Acivity Relationship of Substituted Tetrahydro- and Hexahydro-1,2-benzisothiazol-3-one 1,1-Dioxides and Thiadiazinones: Potential Anxiolytic Agents, J. Med. Chem. (1989) vol. 32:1024-1033. Amer.Chem Soc.
Gauss Carla M.
Gustafson Gary R.
Newcom Jason S.
Anilionis Algis
Cara Therapeutics, Inc.
Habte Kahsay T
LandOfFree
Benzo-fused heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzo-fused heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzo-fused heterocycles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2721603